BRIEF-Sangamo Therapeutics enters into amended and restated agreement with Cowen and Company
* On May 26 co entered into amended and restated at-market offering program sales agreement with Cowen and Company
ZURICH Dec 21 Novartis said on Wednesday it is challenging the Colombian Ministry of Health's decision to lower the price of its cancer drug imatinib (Glivec) by nearly half in an effort to cut health care costs.
The Swiss drugmaker said it was filing an annulment action to challenge the decision to enforce a Declaration of Public Interest, saying it could create a damaging precedent.
"We are pursuing this case out of concern for the repercussions it could have for the intellectual property system and future of innovative medicines," Novartis said in a statement.
(Reporting by John Revill)
SAN ANTONIO, May 26 A former Texas nurse known as the "angel of death" for allegedly having killed up to 60 babies was served a new murder warrant linking her to the death of an infant boy more than 30 years ago, a district attorney said on Friday.